before few years, the united kingdom has witnessed a revolution in medical fat‑decline treatments — with the introduction of semaglutide (Wegovy®) for the escalating level of popularity of tirzepatide (Mounjaro®). Now, An additional title is drawing focus in the two clinical and general public we